Latest Observability News

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals is seeking a re-examination of the European Medicines Agency’s refusal to approve trofinetide for Rett syndrome, aiming to overturn the setback and bring the treatment to European patients.

Maronan Metals has been granted a Mineral Development Licence for its Maronan Silver Project, marking a pivotal step toward mine readiness and enabling underground resource expansion.

Osmond Resources reports promising preliminary testwork results from its Orión EU Critical Minerals Project in Spain, highlighting high-grade zircon and monazite concentrates with strong recovery rates. The company advances towards a scoping study and further beneficiation testing.

Noronex Limited has launched a detailed ground gravity survey over its Cgae Cgae Copper-Silver Project in Botswana, following a recent scout drilling campaign. This marks a key step in refining exploration targets beneath the Kalahari cover.

Rincon Resources has successfully raised $3.1 million to fund an expanded drilling campaign at its promising Telfer South Gold-Copper Project, following the discovery of a significantly larger mineralised zone at the Hasties Prospect.

Amplitude Energy and O.G. Energy have locked in a foundational gas sales agreement with EnergyAustralia, committing to supply 30 PJ of gas from the East Coast Supply Project starting in late 2028. This deal marks a significant step toward the project's development amid ongoing negotiations with other buyers.

Nova Minerals has identified a significant new gold-copper anomaly spanning 1,500 by 800 metres at its West Wing prospect within the Estelle Project in Alaska, based on 2025 surface sampling results. This discovery hints at a potentially distinct deposit style and sets the stage for targeted drilling in 2026.

Resouro Strategic Metals reports encouraging metallurgical testwork results and progress on the Preliminary Economic Assessment for its Tiros Titanium and Rare Earths Project in Brazil, highlighting potential for a globally significant operation.

ClearVue Technologies reported a 9% reduced half-year loss of $5.25 million, while pushing forward with significant advancements in its solar glass technology and expanding global licensing partnerships.

Avecho Biotechnology reported a 9.3% revenue increase alongside a 41.5% rise in net loss for 2025, while progressing its Phase III CBD insomnia trial and securing a significant licensing agreement with Sandoz.

Anteris Technologies Global Corp. posted a $94.2 million loss for 2025 amid a 29% revenue decline, while progressing its pivotal DurAVR THV clinical trial and securing $320 million in early 2026 financings.

Vault Minerals reports a series of high-grade drilling results across its key gold projects, signalling potential life-of-mine extensions and new mining fronts. The findings highlight resource growth opportunities at Leonora, Darlot, Deflector, and Sugar Zone.